Other OTC - Delayed Quote USD

IntelGenx Technologies Corp. (IGXT)

0.1639 -0.0060 (-3.53%)
At close: 3:57 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,039.0000
1,039.0000
950.0000
1,535.0000
1,544.0000
Cost of Revenue
1,733.0000
1,733.0000
1,858.0000
2,256.0000
1,477.0000
Gross Profit
-694.0000
-694.0000
-908.0000
-721.0000
67.0000
Operating Expense
8,797.0000
8,797.0000
8,505.0000
7,261.0000
6,331.0000
Operating Income
-9,491.0000
-9,491.0000
-9,413.0000
-7,982.0000
-6,264.0000
Net Non Operating Interest Income Expense
-1,584.0000
-1,584.0000
-1,277.0000
-1,336.0000
-780.0000
Other Income Expense
1,148.0000
1,148.0000
--
--
--
Pretax Income
-9,927.0000
-9,927.0000
-10,690.0000
-9,318.0000
-7,044.0000
Tax Provision
--
--
--
-6.0000
--
Net Income Common Stockholders
-9,927.0000
-9,927.0000
-10,690.0000
-9,312.0000
-7,044.0000
Diluted NI Available to Com Stockholders
-9,927.0000
-9,927.0000
-10,690.0000
-9,312.0000
-7,044.0000
Basic EPS
-0.06
-0.06
-0.07
-0.07
-0.07
Diluted EPS
-0.06
-0.06
-0.07
-0.07
-0.07
Basic Average Shares
174,651.5900
174,654.5650
164,746.0540
137,003.3130
108,440.8880
Diluted Average Shares
174,651.5900
174,654.5650
164,746.0540
137,003.3130
108,440.8880
Total Operating Income as Reported
-9,491.0000
-9,491.0000
-9,413.0000
-7,982.0000
-6,264.0000
Total Expenses
10,530.0000
10,530.0000
10,363.0000
9,517.0000
7,808.0000
Net Income from Continuing & Discontinued Operation
-9,927.0000
-9,927.0000
-10,690.0000
-9,312.0000
-7,044.0000
Normalized Income
-11,075.0000
-11,075.0000
-10,690.0000
-9,312.0000
-7,044.0000
Interest Income
41.0000
41.0000
4.0000
152.0000
422.0000
Interest Expense
1,625.0000
1,625.0000
1,281.0000
1,488.0000
1,202.0000
Net Interest Income
-1,584.0000
-1,584.0000
-1,277.0000
-1,336.0000
-780.0000
EBIT
-8,302.0000
-8,302.0000
-9,409.0000
-7,830.0000
-5,842.0000
EBITDA
-7,536.0000
-7,536.0000
-8,632.0000
-7,039.0000
-5,108.0000
Reconciled Cost of Revenue
1,733.0000
1,733.0000
1,858.0000
2,256.0000
1,477.0000
Reconciled Depreciation
766.0000
766.0000
777.0000
791.0000
734.0000
Net Income from Continuing Operation Net Minority Interest
-9,927.0000
-9,927.0000
-10,690.0000
-9,312.0000
-7,044.0000
Total Unusual Items Excluding Goodwill
1,148.0000
1,148.0000
--
--
--
Total Unusual Items
1,148.0000
1,148.0000
--
--
--
Normalized EBITDA
-8,684.0000
-8,684.0000
-8,632.0000
-7,039.0000
-5,108.0000
Tax Rate for Calcs
--
--
--
0.0000
--
12/31/2020 - 1/17/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACOGF Alpha Cognition Inc.
0.4950
-3.98%
 
ATAI Atai Life Sciences N.V.
1.9700
+5.35%
 
RLFTF Relief Therapeutics Holding SA
1.4500
0.00%
 
BNOX Bionomics Limited
0.9232
-3.82%
 
PHRRF PharmaTher Holdings Ltd.
0.1666
+4.35%
 
IPIX Innovation Pharmaceuticals Inc.
0.0035
-16.67%
 
ARDS Aridis Pharmaceuticals, Inc.
0.0635
-1.55%
 
NLSP NLS Pharmaceutics Ltd.
0.1302
+0.93%
 
CLABF Core One Labs Inc.
0.1423
-9.74%
 
MDXXF Pharmala Biotech Holdings Inc.
0.1550
0.00%